Meeting of the International Task Force for Disease Eradication, June 2017.
出版信息
Wkly Epidemiol Rec. 2017 Sep 15;92(37):537-56.
PMID:28914042
Abstract
摘要
相似文献
1
Meeting of the International Task Force for Disease Eradication, June 2017.国际疾病根除特别工作组会议，2017年6月
Wkly Epidemiol Rec. 2017 Sep 15;92(37):537-56.
2
World Hepatitis Day 2019 - Bringing Medical Advances to Every Man.2019年世界肝炎日——让医学进步惠及每一个人。
Ann Acad Med Singap. 2019 Jul;48(7):199-200.
3
Consensus statements on the prevention and management of hepatitis B and hepatitis C in the Asia-Pacific region. Core Working Party for Asia-Pacific Consensus on Hepatitis B and C.亚太地区乙型肝炎和丙型肝炎预防与管理共识声明。亚太地区乙型和丙型肝炎共识核心工作小组。
J Gastroenterol Hepatol. 2000 Aug;15(8):825-41. doi: 10.1046/j.1440-1746.2000.02324.x.
4
Global elimination of hepatitis C virus by 2030: why not?到2030年全球消除丙型肝炎病毒：为何不可以？
Nat Med. 2020 Feb;26(2):157-160. doi: 10.1038/s41591-019-0706-x.
5
[Incidence of infectious hepatitis in the Russian Federation and sociomedical measures to prevent its prevalence].[俄罗斯联邦传染性肝炎的发病率及预防其流行的社会医学措施]
Vestn Ross Akad Med Nauk. 2001(8):31-4.
6
[Fighting against viral hepatitis B and C: which policy for prevention?].[抗击乙型和丙型病毒性肝炎：哪种预防政策？]
Rev Prat. 2005 Mar 31;55(6):585-6.
7
The epidemiological changes of HCV and HBV infections in the era of new antiviral therapies and the anti-HBV vaccine.新型抗病毒疗法及乙肝疫苗时代丙型肝炎病毒和乙型肝炎病毒感染的流行病学变化
J Infect Public Health. 2016 Jul-Aug;9(4):389-95. doi: 10.1016/j.jiph.2015.05.004. Epub 2015 Jul 4.
8
Improving communication about viral hepatitis in Africa.改善非洲地区关于病毒性肝炎的沟通。
Lancet Infect Dis. 2017 Jul;17(7):688-689. doi: 10.1016/S1473-3099(17)30339-0. Epub 2017 Jun 21.
9
Control of hepatitis B and C worldwide.全球范围内乙型和丙型肝炎的防控
BMJ. 2009 Oct 28;339:b4431. doi: 10.1136/bmj.b4431.
10
Meeting of the International Task Force for Disease Eradication, April 2015.国际疾病根除特别工作组会议，2015年4月
Wkly Epidemiol Rec. 2015 Jul 31;90(31):384-92.
引用本文的文献
1
Evaluation of the International Task Force for Disease Eradication: A Review of Past Deliberations.评估国际消灭疾病特别工作组：对过去审议情况的回顾。
Am J Trop Med Hyg. 2024 Jul 16;111(3_Suppl):5-11. doi: 10.4269/ajtmh.23-0885. Print 2024 Sep 3.
2
Cryoglobulinemia: the "cold" problem in cardiac surgery, a single-center experience and a literature review.冷球蛋白血症：心脏手术中的“寒冷”问题，单中心经验及文献综述
J Anesth Analg Crit Care. 2024 Jan 25;4(1):6. doi: 10.1186/s44158-024-00141-x.
3
Spatiotemporal heterogeneity and impact factors of hepatitis B and C in China from 2010 to 2018: Bayesian space-time hierarchy model.2010 年至 2018 年中国乙型和丙型肝炎的时空异质性及影响因素：贝叶斯时空层次模型。
Front Cell Infect Microbiol. 2023 Feb 27;13:1115087. doi: 10.3389/fcimb.2023.1115087. eCollection 2023.
4
The global campaign to eliminate HBV and HCV infection: International Viral Hepatitis Elimination Meeting and core indicators for development towards the 2030 elimination goals.全球消除乙肝病毒和丙肝病毒感染运动：国际病毒性肝炎消除会议及迈向2030年消除目标的核心发展指标
J Virus Erad. 2019 Jan 1;5(1):60-66. doi: 10.1016/S2055-6640(20)30281-8.
5
Clinical practice: hepatitis C virus infection, cryoglobulinemia and cryoglobulinemic vasculitis.临床实践：丙型肝炎病毒感染、冷球蛋白血症和冷球蛋白血症性血管炎。
Clin Exp Med. 2019 Feb;19(1):1-21. doi: 10.1007/s10238-018-0536-z. Epub 2018 Nov 14.
Zotero 插件